Stock listing

NASDAQ:OCAT Ocata Therapeutics Inc Stock

Follow Ocata Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:OCAT

$8.47 USD

Close on Feb 9, 2016 · No longer trades

Feb 17, 2005 to last close -98.6% · monthly closes, Feb 17, 2005 – Feb 9, 2016
Lowest – highest close
$1.00 – $700.00 USDSince Feb 17, 2005 · lowest Jul 28, 2008 · highest Feb 18, 2005

Delisted NASDAQ:OCAT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:OCAT
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Ocata Therapeutics Inc on 6ix

Decks
3 decks · latest Feb 9, 2015

Decks

DeckKindSlidesDate
BIO CEO Presentation (February 2015)Conference32 slidesFeb 9, 2015
IPO Roadshow (December 2014)IPO roadshow32 slidesDec 19, 2014
Advanced Cell Technology — Investor Presentation (July 2007)Investor deck55 slidesJul 2, 2007

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Michael Heffernan
Other companies: enGene Therapeutics Inc. (Director · Since at least Jul 8, 2025); Avalo Therapeutics, Inc. (Chairman of the Board · Since at least Mar 25, 2025); Biohaven Ltd. (Director · Since at least Sep 28, 2022); Trevi Therapeutics, Inc. (Lead Independent Director · Since at least May 7, 2019); Synlogic Inc (Director · Dec 8, 2020 – Jun 22, 2023 · Past); Biohaven Pharmaceutical Holding Co Ltd (Director · Jan 31, 2020 – Oct 3, 2022 · Past); Akebia Therapeutics, Inc. (Director · Dec 12, 2018 – Jun 2, 2021 · Past); Keryx Biopharmaceuticals Inc (Director · Jun 21, 2016 – Dec 12, 2018 · Past); Collegium Pharmaceutical, Inc. (Director · May 6, 2015 – Feb 10, 2025 · Past)
Director · Apr 11, 2012 – Feb 10, 2016 · Past
Robert Langer
Other companies: Seer, Inc. (Director · Since at least Dec 3, 2020); Lyra Therapeutics, Inc. (David H. Koch Institute Professor, Massachusetts Institute of Technology · Since at least Apr 30, 2020); Korro Bio, Inc. (Director · Oct 2, 2019 – Aug 17, 2022 · Past); Moderna, Inc. (Director · Dec 7, 2018 – May 6, 2024 · Past); Rubius Therapeutics Inc (Director · Jul 17, 2018 – Oct 14, 2019 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 12, 2018 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Jun 21, 2016 · Past)
Director · Oct 4, 2011 – Feb 10, 2016 · Past
Gregory D Perry
Other companies: Kala Bio, Inc. (Director · Since at least Feb 28, 2018); Novelion Therapeutics Inc (See Remarks · Nov 29, 2016 – May 9, 2017 · Past); Aegerion Pharmaceuticals Inc (See Remarks · Jul 6, 2015 – May 9, 2016 · Past); Eleven Biotherapeutics Inc (Chief Financial and Business · Feb 5, 2014 – Feb 26, 2015 · Past); InVivo Therapeutics Holdings Corp (Interim CFO · Sep 30, 2013 – Dec 30, 2013 · Past); ImmunoGen Inc (Chief Financial Officer · Jan 9, 2009 – Sep 10, 2013 · Past)
Director · Dec 2, 2011 – Feb 10, 2016 · Past
Michael D West
Other companies: Serina Therapeutics, Inc. (Chief Executive Officer · Nov 27, 2018 – Mar 11, 2023 · Past); Insight Molecular Diagnostics Inc. (Director · Dec 30, 2015 – Feb 16, 2016 · Past); Asterias Biotherapeutics Inc (VP of Technology Integration, Director · Feb 13, 2015 – Feb 13, 2015 · Past); Lineage Cell Therapeutics, Inc. (Co-Chief Executive Officer, Director · Dec 31, 2005 – Sep 17, 2018 · Past)
Director · Oct 9, 2007 – Oct 9, 2007 · Past
Alan G Walton
Other companies: ACADIA Pharmaceuticals Inc. (Director · Jun 13, 2006 – Jun 12, 2009 · Past); Avalon Pharmaceuticals Inc (Director · Dec 26, 2005 – Jan 2, 2008 · Past); Alexandria Real Estate Equities, Inc. (Director · Jan 14, 2005 – Dec 30, 2011 · Past)
Director · Jan 26, 2006 – Jan 26, 2006 · Past
Edward H Myles
Other companies: Scholar Rock Holding Corporation (COO & CFO · Nov 19, 2018 – Mar 10, 2025 · Past); AMAG Pharmaceuticals Inc (COO & CFO · Apr 11, 2016 – Mar 10, 2020 · Past); Pressure BioSciences, Inc. (Senior VP of Finance & CFO · Apr 3, 2006 – Sep 25, 2008 · Past)
COO & CFO · Jun 12, 2013 – Feb 10, 2016 · Past
Paul Wotton
Other companies: Vericel Corporation (Director · Since at least Jan 6, 2015); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past); Antares Pharma Inc (President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past)
President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past
Brian Levy
Other companies: Aerie Pharmaceuticals Inc. (Chief Medical Officer · Oct 25, 2013 – Feb 25, 2015 · Past); InSite Vision Inc (Director · Aug 15, 2011 – Nov 2, 2015 · Past)
Director · Aug 31, 2015 – Feb 10, 2016 · Past
Erkki Ruoslahti
Other companies: Lisata Therapeutics, Inc. (Director · Sep 15, 2022 – Jan 9, 2023 · Past)
Director · Jan 26, 2006 – Mar 4, 2011 · Past
Pedro Huertas
Other companies: Inozyme Pharma Inc (SVP, CMO · Jul 23, 2020 – Jan 13, 2021 · Past)
Chief Development Officer · Feb 5, 2007 – Sep 7, 2007 · Past
All 17 people
PersonSeat
Alan C ShapiroDirector · Jan 26, 2006 – Feb 10, 2016 · Past
Eddy AngladeChief Medical Officer · Jan 6, 2014 – Feb 10, 2016 · Past
Gary H RabinCEO & CFO, Director · Feb 4, 2010 – Apr 15, 2013 · Past
H Le Roux JoosteSVP of Bus Development & CCO · Oct 14, 2014 – Feb 10, 2016 · Past
Jonathan DinsmoreSVP, Clinical & Regulatory · Nov 1, 2007 – Feb 6, 2008 · Past
Robert LanzaChief Scientific Officer · Aug 17, 2006 – Feb 10, 2016 · Past
William M CaldwellChief Executive Officer, Director · Dec 8, 2006 – Nov 13, 2009 · Past

Open People

Log in to ask 6ix AI your own questions about Ocata Therapeutics Inc.